News Chart InnoCan Pharma Corporation

Equities

INNO

CA45783P1027

Market Closed - Canadian Securities Exchange Other stock markets 03:56:47 2024-05-10 pm EDT			5-day change	1st Jan Change
0.32 ^CAD	-3.03%		+18.52%	+3.23%

May. 09	Innocan Pharma Corporation Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey	CI
Apr. 22	InnoCan Pharma Corporation Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain	CI

8e0078b48cee00573e26f728c84.2sOYDZavmFe7lddhq4ykOQSSZFAZqaQzNvz1l_b4oIk.tonAXvDh2ifx97lR-rWSdnLeMAVfxP54aa6U5ITLx7Crl9RM2v78D_-kuA~3240c0ff68d08e0ab520da3bfd07a734